RedHill Biopharma RDHL
NASDAQ RDHL
$0.65 +0.02 (+3.29%)
At close: Aug 20, 2026 · 10:57 AM UTC

RedHill Biopharma (RDHL) Operating Leases (2019 - 2025)

RedHill Biopharma (RDHL) posted quarterly Operating Leases of $900000.0 for Q4 2025, up 29900.0% year-over-year from N/an in Q4 2024, and up 29900.0% quarter-over-quarter from $3000.0 in Q4 2024.

RedHill Biopharma (RDHL) Operating Leases (2019 - 2025) Analysis & Trends

RedHill Biopharma (RDHL) has reported Operating Leases for 7 consecutive years, with $900000.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Operating Leases rose 29900.0% year-over-year to $900000.0; the TTM figure through Dec 2025 stood at $900000.0 (up 29900.0% YoY), while the FY2025 annual figure was $900000.0, up 29900.0% from the prior year.
  • Operating Leases climbed to $900000.0 in Q4 2025 per RDHL's latest filing, from $3000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $6.7 million in Q2 2022 and bottomed at $3000.0 in Q4 2024.
  • Historically, Operating Leases has averaged $2.6 million across 5 years, with a median of $1.8 million in 2021.
  • Annual changes were most pronounced in 2024 — Operating Leases slumped 99.34% — and 2025, when it surged 29900.0%.
  • RedHill Biopharma's Operating Leases stood at $2.6 million in 2021, then surged by 150.31% to $6.4 million in 2022, then tumbled by 92.94% to $455000.0 in 2023, then plunged by 99.34% to $3000.0 in 2024, then soared by 29900.0% to $900000.0 in 2025.
  • Business Quant data shows RDHL's Operating Leases at $900000.0 in Q4 2025, $3000.0 in Q4 2024, and $190000.0 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.89 Bn 42.93 Bn -
2 Teva Pharmaceutical Industries 43.01 Bn 39.35 Bn 2.15 Bn
3 Zoetis 31.52 Bn 29.84 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn
5 United Therapeutics 22.17 Bn 19.51 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.85 Bn 1.46 Bn
7 Neurocrine Biosciences 15.51 Bn 15.12 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn -
10 RedHill Biopharma 2.05 Bn 2.05 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 900,000.00
Dec 31, 2024 3,000.00
Jun 30, 2024 190,000.00
Dec 31, 2023 455,000.00
Jun 30, 2023 994,000.00
Dec 31, 2022 6.44 Mn
Jun 30, 2022 6.67 Mn
Mar 31, 2022 4.80 Mn
Dec 31, 2021 2.57 Mn
Jun 30, 2021 2.98 Mn
Dec 31, 2020 3.81 Mn
Jun 30, 2020 4.04 Mn
Dec 31, 2019 2.98 Mn
Jun 30, 2019 3.23 Mn